manilatimes4d
Sixty Degrees Pharmaceuticals to Ensure Continuity of Tafenoquine Supply in U.S. by Importing Limited Quantity of KODATEF®
KODATEF is not approved for use in the U.S. Demand for ARAKODA has been steadily growing in recent months as awareness and ...
Taiwan News18d
60 Degrees Pharma Announces IRB Approval of Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis
Hemolytic Anemia: G6PD testing must be performed before prescribing ARAKODA® due to the risk of hemolytic anemia. Monitor patients for signs or symptoms of hemolysis. G6PD Deficiency in Pregnancy or ...
Nasdaq18d
60 Degrees Pharma Announces IRB Approval of Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis
Hemolytic Anemia: G6PD testing must be performed before prescribing ARAKODA® due to the risk of hemolytic anemia. Monitor patients for signs or symptoms of hemolysis. G6PD Deficiency in ...
Medscape20d
Approaches to Treating Chronic Anemia in Developing Countries
while the most prevalent red cell enzyme disorder is G6PD deficiency. [27] A definitive diagnosis of sickle cell anemia requires Hb electrophoresis and a demonstration of a sickle cell trait in ...